A Phase 4 Comparison of Duloxetine Dosing Strategies in the Treatment of Korean Patients With Major Depressive Disorder.
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2012
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Eli Lilly
- 23 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Dec 2010 Planned end date changed from Jan 2011 to Apr 2011 as reported by ClinicalTrials.gov.